These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

742 related articles for article (PubMed ID: 25994188)

  • 61. Management of elderly patients with congestive heart failure--design of the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF).
    Brunner-La Rocca HP; Buser PT; Schindler R; Bernheim A; Rickenbacher P; Pfisterer M;
    Am Heart J; 2006 May; 151(5):949-55. PubMed ID: 16644310
    [TBL] [Abstract][Full Text] [Related]  

  • 62. JinQi-Jiangtang tablet, a Chinese patent medicine, for pre-diabetes: a randomized controlled trial.
    Cao H; Ren M; Guo L; Shang H; Zhang J; Song Y; Wang H; Wang B; Li X; Hu J; Wang X; Wang D; Chen J; Li S; Chen L
    Trials; 2010 Mar; 11():27. PubMed ID: 20214831
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Novel Mitochondria-Targeting Peptide in Heart Failure Treatment: A Randomized, Placebo-Controlled Trial of Elamipretide.
    Daubert MA; Yow E; Dunn G; Marchev S; Barnhart H; Douglas PS; O'Connor C; Goldstein S; Udelson JE; Sabbah HN
    Circ Heart Fail; 2017 Dec; 10(12):. PubMed ID: 29217757
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clinical efficacy and safety of Danhong injection for the treatment of chronic heart failure: A protocol for systematic review.
    Han L; Wang C; Yao D; Wang B; Zhang Z; Liu J
    Medicine (Baltimore); 2020 Apr; 99(14):e19526. PubMed ID: 32243368
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study.
    Olsen SL; Gilbert EM; Renlund DG; Taylor DO; Yanowitz FD; Bristow MR
    J Am Coll Cardiol; 1995 May; 25(6):1225-31. PubMed ID: 7722114
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Common clinical medical combinations with Shenfu injection based on 25 704 electronic medical records].
    Peng SY; Yang W; Xie YM; Li L; Zhuang Y
    Zhongguo Zhong Yao Za Zhi; 2015 Jun; 40(12):2435-9. PubMed ID: 26591538
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cardiac structure and function improvements in coronary artery disease combined with severe obstructive sleep apnea/hypopnea syndrome patients via noninvasive positive pressure ventilation therapy.
    Liu X; Feng L; Cao G; Huang H; Xu Q; Yu J; Zhang S; Zhou M
    Coron Artery Dis; 2014 Sep; 25(6):516-20. PubMed ID: 24870115
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of yangxinkang tablets on chronic heart failure: A multi-center randomized double-blind placebo-controlled trial.
    Xian SX; Yang ZQ; Ren PH; Ye XH; Ye SL; Wang QH; Wang ZH; Shen SJ; Huang XW
    Chin J Integr Med; 2015 Oct; 21(10):733-42. PubMed ID: 25948124
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparative efficacy of five Chinese medicine injections for treating dilated cardiomyopathy with heart failure: A Bayesian network meta-analysis.
    Cao X; Liu H; Zhou M; Chen X; Long D
    J Ethnopharmacol; 2022 Jan; 282():114604. PubMed ID: 34499964
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of levosimendan on estimated glomerular filtration rate in hospitalized patients with decompensated heart failure and renal dysfunction.
    Hou ZQ; Sun ZX; Su CY; Tan H; Zhong X; Hu B; Zhou Y; Shang DY
    Cardiovasc Ther; 2013 Apr; 31(2):108-14. PubMed ID: 23490237
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Efficacy of shenfu injection as adjuvant therapy in treating patients of ischemic cardiomyopathy with heart insufficiency].
    Luo XY; Zhang FR; He RM
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Aug; 29(8):685-7. PubMed ID: 19848196
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The irbesartan in heart failure with preserved systolic function (I-PRESERVE) trial: rationale and design.
    Carson P; Massie BM; McKelvie R; McMurray J; Komajda M; Zile M; Ptaszynska A; Frangin G;
    J Card Fail; 2005 Oct; 11(8):576-85. PubMed ID: 16230259
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effect of pimobendan in addition to standard therapy for heart failure on prevention of readmission in elderly patients with severe chronic heart failure.
    Kawano H; Arakawa S; Satoh O; Matsumoto Y; Hayano M; Nakatomi D; Yamasa T; Maemura K
    Geriatr Gerontol Int; 2014 Jan; 14(1):109-14. PubMed ID: 23581555
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Interleukin-1 blockade in heart failure with preserved ejection fraction: rationale and design of the Diastolic Heart Failure Anakinra Response Trial 2 (D-HART2).
    Van Tassell BW; Buckley LF; Carbone S; Trankle CR; Canada JM; Dixon DL; Abouzaki N; Oddi-Erdle C; Biondi-Zoccai G; Arena R; Abbate A
    Clin Cardiol; 2017 Sep; 40(9):626-632. PubMed ID: 28475816
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Efficacy and safety of Suxiao Jiuxin Pill in the treatment of stable angina (Qi stagnation and blood stasis syndrome): study protocol of a randomized, double-blind, placebo-controlled, multi-center clinical trial.
    Ruan X; Li Y; Sun Y; Jia M; Xu X; Huo L; Song W; Yao Y; Wang X
    Trials; 2021 Jul; 22(1):466. PubMed ID: 34281600
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)-a multicentre, double-blind, randomised, placebo-controlled trial.
    Jorsal A; Kistorp C; Holmager P; Tougaard RS; Nielsen R; Hänselmann A; Nilsson B; Møller JE; Hjort J; Rasmussen J; Boesgaard TW; Schou M; Videbaek L; Gustafsson I; Flyvbjerg A; Wiggers H; Tarnow L
    Eur J Heart Fail; 2017 Jan; 19(1):69-77. PubMed ID: 27790809
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effects of Yangxinshi tablet on exercise tolerance in patients with coronary heart disease: A protocol of randomized, double-blind, placebo-controlled, and multi-center trial.
    Zhang S; Liang C; Yang Y; Zhao Z; Li J; Meng X
    Medicine (Baltimore); 2020 Jul; 99(31):e21485. PubMed ID: 32756176
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Antiremodeling effect of long-term exercise training in patients with stable chronic heart failure: results of the Exercise in Left Ventricular Dysfunction and Chronic Heart Failure (ELVD-CHF) Trial.
    Giannuzzi P; Temporelli PL; Corrà U; Tavazzi L;
    Circulation; 2003 Aug; 108(5):554-9. PubMed ID: 12860904
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial.
    Mortensen SA; Rosenfeldt F; Kumar A; Dolliner P; Filipiak KJ; Pella D; Alehagen U; Steurer G; Littarru GP;
    JACC Heart Fail; 2014 Dec; 2(6):641-9. PubMed ID: 25282031
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effects of Kanlijian on exercise tolerance, quality of life, and frequency of heart failure aggravation in patients with chronic heart failure.
    Jiang MX; Ruan XF; Xu Y
    Chin J Integr Med; 2006 Jun; 12(2):94-100. PubMed ID: 16800986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.